121 related articles for article (PubMed ID: 24239882)
1. Regulation of adult hematopoiesis by the a disintegrin and metalloproteinase 10 (ADAM10).
Weber S; Wetzel S; Prox J; Lehmann T; Schneppenheim J; Donners M; Saftig P
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):234-41. PubMed ID: 24239882
[TBL] [Abstract][Full Text] [Related]
2. Dual functions of cell-autonomous and non-cell-autonomous ADAM10 activity in granulopoiesis.
Yoda M; Kimura T; Tohmonda T; Uchikawa S; Koba T; Takito J; Morioka H; Matsumoto M; Link DC; Chiba K; Okada Y; Toyama Y; Horiuchi K
Blood; 2011 Dec; 118(26):6939-42. PubMed ID: 22042698
[TBL] [Abstract][Full Text] [Related]
3. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch.
Gibb DR; Saleem SJ; Kang DJ; Subler MA; Conrad DH
J Immunol; 2011 Apr; 186(7):4244-52. PubMed ID: 21368228
[TBL] [Abstract][Full Text] [Related]
5. Effects of ADAM10 deletion on Notch-1 signaling pathway and neuronal maintenance in adult mouse brain.
Zhuang J; Wei Q; Lin Z; Zhou C
Gene; 2015 Jan; 555(2):150-8. PubMed ID: 25445276
[TBL] [Abstract][Full Text] [Related]
6. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
[TBL] [Abstract][Full Text] [Related]
7. Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
Folgosa L; Zellner HB; El Shikh ME; Conrad DH
J Immunol; 2013 Dec; 191(12):5951-8. PubMed ID: 24227779
[TBL] [Abstract][Full Text] [Related]
8. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
9. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.
Gibb DR; El Shikh M; Kang DJ; Rowe WJ; El Sayed R; Cichy J; Yagita H; Tew JG; Dempsey PJ; Crawford HC; Conrad DH
J Exp Med; 2010 Mar; 207(3):623-35. PubMed ID: 20156974
[TBL] [Abstract][Full Text] [Related]
11. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex.
Jorissen E; Prox J; Bernreuther C; Weber S; Schwanbeck R; Serneels L; Snellinx A; Craessaerts K; Thathiah A; Tesseur I; Bartsch U; Weskamp G; Blobel CP; Glatzel M; De Strooper B; Saftig P
J Neurosci; 2010 Apr; 30(14):4833-44. PubMed ID: 20371803
[TBL] [Abstract][Full Text] [Related]
12. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.
Hikita A; Tanaka N; Yamane S; Ikeda Y; Furukawa H; Tohma S; Suzuki R; Tanaka S; Mitomi H; Fukui N
Biochem Cell Biol; 2009 Aug; 87(4):581-93. PubMed ID: 19767822
[TBL] [Abstract][Full Text] [Related]
14. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
[TBL] [Abstract][Full Text] [Related]
15. RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity.
Muraguchi T; Takegami Y; Ohtsuka T; Kitajima S; Chandana EP; Omura A; Miki T; Takahashi R; Matsumoto N; Ludwig A; Noda M; Takahashi C
Nat Neurosci; 2007 Jul; 10(7):838-45. PubMed ID: 17558399
[TBL] [Abstract][Full Text] [Related]
16. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.
Deuss M; Reiss K; Hartmann D
Curr Alzheimer Res; 2008 Apr; 5(2):187-201. PubMed ID: 18393804
[TBL] [Abstract][Full Text] [Related]
17. Targeting of retinal axons requires the metalloproteinase ADAM10.
Chen YY; Hehr CL; Atkinson-Leadbeater K; Hocking JC; McFarlane S
J Neurosci; 2007 Aug; 27(31):8448-56. PubMed ID: 17670992
[TBL] [Abstract][Full Text] [Related]
18. Assignment of a disintegrin and metalloproteinase domain 10 (Adam10) gene to mouse chromosome 9.
Yamazaki K; Mizui Y; Sagane K; Tanaka I
Genomics; 1997 Dec; 46(3):528-9. PubMed ID: 9441766
[No Abstract] [Full Text] [Related]
19. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
20. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo.
Endres K; Mitteregger G; Kojro E; Kretzschmar H; Fahrenholz F
Neurobiol Dis; 2009 Nov; 36(2):233-41. PubMed ID: 19632330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
